India’s first dengue vaccine arrives with a crucial safety caveat
India’s drug regulator just approved the country’s first dengue vaccine, Qdenga. It is designed and claimed to protect against the four serotypes of the dengue-causing virus, called DENV-1 to DENV-4. Young children as well as adults (aged 4-60 years), irrespective of whether they have had dengue before, may be vaccinated with Qdenga. More than 40…
Read More “India’s first dengue vaccine arrives with a crucial safety caveat” »
